Filing excerpt
On January 30, 2026, the Company completed the Transaction. The Company paid a purchase price of $350,000,000 in cash, subject to customary adjustments.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Vendors
Regions named
sec-8kcapexIncreaseGet every 8-K signal for Illumina and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Illumina this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/65339df3-4d65-4eea-9a15-352523fdfebb returns this record as JSON. POST /v1/companies/enrich returns every signal for illumina.com.
{
"signal_id": "65339df3-4d65-4eea-9a15-352523fdfebb",
"signal_type": "sec-8k",
"signal_subtype": "capexIncrease",
"detected_at": "2026-02-03T13:18:31.341+00:00",
"company": {
"name": "Illumina",
"domain": "illumina.com"
},
"data": {
"detail": "Illumina acquired SomaLogic and Sengenics for $350M, creating urgent needs for post-merger integration of technology, operations, and product portfolios. This strategic expansion into proteomics presents opportunities for vendors specializing in system consolidation, data migration, and change management to support the integration.",
"metrics": {
"timeframe": "immediate",
"dollar_context": "Initial cash purchase price for Standard BioTools's proteomics business, with up to an additional $75M in potential milestone payments.",
"dollar_millions": 350
},
"summary": "Illumina completes $350M cash acquisition of proteomics business from Standard BioTools",
"excerpts": "On January 30, 2026, the Company completed the Transaction. The Company paid a purchase price of $350,000,000 in cash, subject to customary adjustments.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080326000014/ilmn-20260130.htm",
"filing_date": "2026-01-30",
"filing_year": 2026,
"sales_relevance": "Budget available",
"signal_category": "financial",
"regions_mentioned": [
"Singapore"
],
"vendors_mentioned": [
"Standard BioTools Inc."
],
"technologies_mentioned": [
"proteomics",
"aptamer-based",
"mass cytometry",
"microfluidics"
]
}
}
curl https://signals.autobound.ai/v1/signals/65339df3-4d65-4eea-9a15-352523fdfebb \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"illumina.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.